To determine whether P450 aromatase was a key enzyme for estrogen and for aromatase inhibitors blocking the conversion of androgen into estrogen, we prepared a PCOS research model with letrozole, a non-steroidal aromatase inhibitor. Here, CYP19A1 is linked to polycystic ovary syndrome.